Skip to main content

Common Dreams. Journalism funded by people, not corporations.

There has never been—and never will be—an advertisement on our site except for this one: without readers like you supporting our work, we wouldn't exist.

No corporate influence. No pay-wall. Independent news and opinion 365 days a year that is freely available to all and funded by those who support our mission: To inform. To inspire. To ignite change for the common good.

Our mission is clear. Our model is simple. If you can, please support our Fall Campaign today.

Support Our Work -- No corporate influence. No pay-wall. Independent news funded by those who support our mission: To inform. To inspire. To ignite change for the common good. Please support our Fall Campaign today.

For Immediate Release

Press Release

MSF: Expected FDA Approval of Pfizer and Moderna COVID-19 Vaccine Highlights Need for Global Approach to End the Pandemic

Vaccines will only be available for everyone who needs them if pharmaceutical corporations share their product information and don’t block production by additional manufacturers.
NEW YORK/GENEVA -

As the US Food and Drug Administration (FDA) discusses emergency use authorization of Pfizer/BioNTech and Moderna’s COVID-19 vaccine candidate, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) highlights the need for a global approach to ensure that all people can benefit from these medical breakthroughs. The hope that these vaccines will help to end this pandemic will not materialize unless all corporations take urgent steps to increase cooperation with other producers and sell the vaccines at-cost. This will mean sharing all the necessary intellectual property (IP), technologies, data, and know-how so that as many companies as possible can produce these lifesaving vaccines that are desperately needed to end the pandemic.

“While the world waits with bated breath for the possible approval of these COVID-19 vaccines, we can’t celebrate until everyone who needs them can get one,” said Dr. Sidney Wong, executive co-director of MSF’s Access Campaign. “Right now, we’re in a situation where the lion’s share of the limited number of first doses have already been bought by a handful of countries like the US and UK, as well as the EU, leaving very little for other countries in the short term. What we really want to see is a rapid expansion of the overall global supply so there are more vaccines to go around and doses can be allocated according to WHO’s public health criteria, not a country’s ability to pay more than others.”

Moderna has been the only company to commit to not enforcing its patents on COVID-19 vaccines during the pandemic. However, in order to make this promise most meaningful, Moderna should also share all IP, technologies, data, and know-how so that other manufacturers can scale-up production of these potentially lifesaving vaccines. Pfizer/BioNTech—whose vaccine was authorized for emergency use by the UK—have indicated no plans to license or transfer their IP-protected technologies. To increase global manufacturing capacity and supply, Pfizer/BioNTech should pursue global open-licensing and engage in full technology transfers to other vaccine manufacturers.

Withholding this information and standing in the way of other manufactures who want to produce more of these vaccines is especially unnecessary considering the significant public funding from governments both companies received to offset the cost of research and development (R&D). However, none of this taxpayer money had conditions attached to guarantee equitable access for everyone, including requiring companies to transfer all technology to other vaccine manufacturers, be transparent about their costs, or sell the vaccines at-cost.

Transparency across the board is also critical to ensure everyone can be vaccinated against COVID-19. Not having access to this information means the public cannot assess whether the prices the companies end up charging are actually fair and affordable. Additionally, without all the information, governments won’t be able to negotiate lower prices based on the true costs of R&D. Both corporations have kept important information including R&D, clinical trial, and manufacturing costs under wraps and out of the public’s view. Unlike other COVID-19 vaccine developers, such as AstraZeneca, that have pledged to sell their vaccine at a “no profit” price during the pandemic, both Pfizer and Moderna have said they will not sell their COVID-19 vaccines at-cost.

Moderna has received nearly $2.5 billion in US government public funds, and yet it has been reported that Moderna has proposed a price of $50-74 per person (for the required two doses) for high-income countries, including the US. This is one of the highest prices for a potential COVID-19 vaccine cited to date. It is not clear at this point how much they plan to charge in low- or middle-income countries. The Pfizer vaccine candidate development was supported by a grant of nearly $443 million from the German government through its partner BioNTech, as well as a loan of more than $118 million from the European Investment Bank. Pfizer is reportedly aiming for a price of $40 per person (for the required two doses).

“In a moment of such important advancements that provide a lot of hope, it is disheartening to see pharma keep information that’s crucial for ensuring access and affordability hidden from public scrutiny,” said Dana Gill, US policy advisor for MSF’s Access Campaign. “Pharma and governments are shirking their responsibilities to the taxpayers and public entities who funded the development of these vaccines and will pay for them. The public has a right to know. Pfizer and Moderna should set a new example of accountability. No company should be allowed to profiteer off the back of this pandemic.”

###

Doctors Without Borders/Médecins Sans Frontières (MSF) is an international medical humanitarian organization created by doctors and journalists in France in 1971. MSF's work is based on the humanitarian principles of medical ethics and impartiality. The organization is committed to bringing quality medical care to people caught in crisis regardless of race, religion, or political affiliation.
MSF operates independently of any political, military, or religious agendas.

Corporate Dems of US Senate Blamed as GOP Texas Governor Approves 'Rigged' Voting Maps

"We must protect our democracy with federal legislation immediately and defeat these cynical politicians at the ballot box."

Jessica Corbett ·


'An Act of Cowardice': 21 Israel-Based Groups Condemn Terror Label for Palestine NGOs

The organizations called the designation "a draconian measure that criminalizes critical human rights work."

Brett Wilkins ·


The Facebook Papers Spur More Calls to 'Break Them Up!'

Other critics are demanding a "full, independent, outside investigation" of the tech titan as whistleblower Frances Haugen testifies to the U.K. Parliament.

Jessica Corbett ·


'This Is an Emergency': Oxfam Says Rich Nations' $100 Billion Climate Pledge Not Good Enough

"Time is running out for rich nations to build trust and deliver on their unmet target."

Andrea Germanos ·


Progressives Vow to 'Push Very Hard' to Keep Agenda From Being Gutted Beyond Recognition

Congresswoman Ilhan Omar said House Democrats "are fighting to tackle the climate crisis, expand Medicare to cover dental, vision, and hearing, and guarantee family leave in America."

Kenny Stancil ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo